Atlas Trials

A Study to Evaluate the Safety, Tolerability and Pharmacokinetics/Pharmacodynamics of Oral Doses of H008

Clinical trial NCT05050188 · COMPLETED

Trial details

NCT number
NCT05050188
Sponsor
Jiangsu Carephar Pharmaceutical Co., Ltd.
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Erosive Esophagitis
Start date
2021-06-24
Primary completion
2021-09-18
Enrollment
24

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.